OBO_ID (LABEL):	CHEBI_50845 (doxycycline)

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
PMC3781185	7/2013	S39-PMC3781185	['Blood Glutathione Redox status and global methylation (pp.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CHEBI_16856', 'glutathione', 6, 'Glutathione'), ('CHEBI_50845', 'doxycycline', 18, 'Redox')]
PMC3820434	12/2012	S110-PMC3820434	['indeed, Ox-ldl increased Triglyceride Production by inducing the Expression of lipoprotein Lipase (Lpl) [52] and by inducing the accumulation of Fa in Adipocytes [53].']	N/A	N/A	[('CHEBI_50845', 'doxycycline', 8, 'ox'), ('CHEBI_17855', 'triglyceride', 25, 'triglyceride'), ('GO_0071604', 'transforming growth factor beta production', 25, 'triglyceride production'), ('GO_0010467', 'gene expression', 65, 'expression'), ('PR_000009875', 'E3 ubiquitin-protein ligase LNX', 91, 'lipase'), ('PR_000009880', 'Lon protease, mitochondrial', 99, 'LPL'), ('CHEBI_30751', 'formic acid', 145, 'FA'), ('CL_0000136', 'fat cell', 151, 'adipocytes')]
PMC4251881	11/2014	S117-PMC4251881	['other treatments consist of ivig, Doxycycline/Minocycline, plasmapheresis, or chemical oophorectomy with Goserelin.']	N/A	N/A	[('CHEBI_50845', 'doxycycline', 34, 'doxycycline'), ('CHEBI_50694', 'minocycline', 46, 'minocycline'), ('CHEBI_42098', 'digoxigenin', 105, 'goserelin')]
PMC4693404	12/2015	S93-PMC4693404	['caption (table-wrap): table 4\n\nmedication-related problems identified by students during the Medication Reconciliation patient projecttype of Medication problemnumber of patients impactedmedicationstherapeutic duplication62 Proton pump Inhibitors (2), 2 Statins, 2 beta Blockers (3)therapeutic omission at discharge8clopidogrel, ramipril, Ranitidine, Vitamin B12 injection, Budesonide, lisinopril, tums, Prenatal vitamins, carvedilolpatient did not take medications listed in electronic health record (non-adherence)11lisinopril, Bupropion, Aspirin, multivitamin, Pantoprazole (2), Omeprazole, Metformin, Levothyroxine, Ergocalciferol, Pravastatin, Furosemide, Bactrim, antipsychoticmedications used by patients but not listed in electronic health record14fiber, Bisacodyl, Pantoprazole, Pravastatin, magnesium, vitamin b, Ciprofloxacin, reservatol, coq-10, ramipril, Ondansetron, Tylenol, Vitamin b-12, tramadol, Aspirin, Glyburide, ventolin, Multivitamin, Dexamethasonedischarge list included a Drug that should have been discontinued1griseofulvindosage too high4warfarin, Aspirin, Oxycodone, Clonidinedosage too low9furosemide, Omeprazole, Doxycycline, Levothyroxine, Insulin, Hydrochlorothiazide, gabapentin, Glimepiride, lisinopril, welcholdrug-disease interaction2omeprazole, Diclofenacdrug-Drug interaction16amlodipine-Simvastatin (2)Oxybutynin-potassiumescitalopram-Pantoprazolemethotrexate-Pantoprazolesulfamethoxazole/Trimethoprim-Methotrexatepotassium-Spironolactonehydrochlorothiazide-Vitamin Dhydrochlorothiazide -Nsaidsaspirin-Furosemidefluconazole-Citalopramrisperdone-Ropinerolewarfarin (unspecified)currently having an adverse drug event16omeprazole, warfarin (3), Simvastatin, Metoprolol, lasix, Amlodipine, lisinopril, Insulin, Glimepiride, antiretroviral, Clonidine, Tramadol, Tobramycin, pravastatin, Hydrochlorothiazide, Medroxyprogesterone, Metformin, Risperidonelack of indication for medication6omprepazole, promethazine, reservatol, Vitamin E, Coq10, wellbutrin, cinnamon, colchicine, viagrapreviously documented allergy, intolerance, or side effect1tenofovirtaking brand when generic is available1simvastatin\nout of the 38 patients who completed a questionnaire before medication reconciliation with a student, 14 patients (37\xa0%) also completed a second questionnaire about their Medication knowledge by phone or mail 3 to 6\xa0months after the student interaction.']	N/A	N/A	[('CHEBI_60211', 'compound Z', 93, 'medication'), ('GO_0032124', 'macronucleus organization', 93, 'medication reconciliation'), ('CHEBI_60211', 'compound Z', 142, 'medication'), ('CHEBI_24636', 'proton', 224, 'proton'), ('CHEBI_35222', 'inhibitor', 236, 'inhibitors'), ('CHEBI_9290', 'strigol', 254, 'statins'), ('CHEBI_35225', 'buffer', 270, 'blockers'), ('CHEBI_8776', 'ranitidine', 339, 'Ranitidine'), ('CHEBI_28334', 'malonamoyl-CoA', 351, 'Vitamin B12'), ('PR_000017279', 'testis-specific basic protein Y 1', 351, 'Vitamin B12'), ('CHEBI_3220', 'Bupropion hydrochloride', 374, 'Budesonide'), ('GO_0007565', 'female pregnancy', 404, 'Prenatal'), ('CHEBI_3219', 'bupropion', 530, 'Bupropion'), ('CHEBI_18388', 'apigenin', 541, 'Aspirin'), ('CHEBI_7915', 'pantoprazole', 564, 'Pantoprazole'), ('CHEBI_7772', 'omeprazole', 582, 'Omeprazole'), ('CHEBI_6801', 'metformin', 594, 'Metformin'), ('CHEBI_6411', 'Leptodactylone', 605, 'Levothyroxine'), ('CHEBI_4822', 'ergometrine', 620, 'Ergocalciferol'), ('CHEBI_63618', 'pravastatin', 636, 'Pravastatin'), ('CHEBI_47426', 'furosemide', 649, 'Furosemide'), ('CHEBI_3088', 'bilanafos', 661, 'Bactrim'), ('CHEBI_3125', 'Bisacodyl', 763, 'Bisacodyl'), ('CHEBI_7915', 'pantoprazole', 774, 'Pantoprazole'), ('CHEBI_63618', 'pravastatin', 788, 'Pravastatin'), ('CHEBI_3703', 'cinchonidine', 823, 'Ciprofloxacin'), ('CHEBI_7773', 'Ondansetron', 868, 'Ondansetron'), ('CHEBI_32265', 'triprolidine hydrochloride monohydrate', 881, 'Tylenol'), ('CHEBI_33229', 'vitamin (role)', 890, 'Vitamin'), ('CHEBI_18388', 'apigenin', 914, 'Aspirin'), ('CHEBI_5441', 'glyburide', 923, 'Glyburide'), ('CHEBI_7025', 'mupirocin', 944, 'Multivitamin'), ('CHEBI_82439', 'Dibenzo[a,e]fluoranthene', 958, 'DexamethasoneDischarge'), ('CHEBI_23888', 'drug', 997, 'Drug'), ('CHEBI_18388', 'apigenin', 1075, 'Aspirin'), ('CHEBI_7852', 'oxycodone', 1084, 'Oxycodone'), ('CHEBI_3756', 'clonazepam', 1095, 'ClonidineDosage'), ('CHEBI_7772', 'omeprazole', 1131, 'Omeprazole'), ('CHEBI_50845', 'doxycycline', 1143, 'Doxycycline'), ('CHEBI_6411', 'Leptodactylone', 1156, 'Levothyroxine'), ('PR_000045358', 'insulin family protein', 1171, 'Insulin'), ('CHEBI_5784', 'hydroflumethiazide', 1180, 'Hydrochlorothiazide'), ('CHEBI_5383', 'glimepiride', 1213, 'Glimepiride'), ('CHEBI_48563', 'methylsulfanyl group', 1282, 'DiclofenacDrug'), ('CHEBI_23888', 'drug', 1297, 'Drug'), ('CHEBI_9150', 'simvastatin', 1326, 'simvastatin'), ('CHEBI_8661', 'Pyrethrosin', 1341, 'Oxybutynin'), ('CHEBI_5015', 'ferbam', 1374, 'pantoprazoleMethotrexate'), ('CHEBI_67598', '20(29)-lupene-1beta,3alpha-diol', 1399, 'pantoprazoleSulfamethoxazole'), ('CHEBI_45924', 'trimethoprim', 1428, 'trimethoprim'), ('CHEBI_50682', 'methotrexate monosodium', 1441, 'methotrexatePotassium'), ('CHEBI_82588', '4-(Methylnitrosamino)-1-(1-oxido-3-pyridinyl)-1-butanone', 1463, 'spironolactoneHydrochlorothiazide'), ('CHEBI_83540', 'bisperfluorodecyl phosphate', 1497, 'vitamin DHydrochlorothiazide'), ('CHEBI_7640', 'nortriptyline', 1527, 'NSAIDsAspirin'), ('CHEBI_83920', '4-(4-chlorophenyl)-2-phenyl-2-(1,2,4-triazol-1-ylmethyl)butanenitrile', 1541, 'furosemideFluconazole'), ('CHEBI_65650', 'colossolactone VII', 1563, 'citalopramRisperdone'), ('CHEBI_68333', 'robinetinidol-(4alpha,8)-catechin', 1584, 'ropineroleWarfarin'), ('CHEBI_9150', 'simvastatin', 1682, 'Simvastatin'), ('CHEBI_6904', 'metoprolol', 1695, 'Metoprolol'), ('CHEBI_2666', 'amitriptyline', 1714, 'Amlodipine'), ('PR_000045358', 'insulin family protein', 1738, 'Insulin'), ('CHEBI_5383', 'glimepiride', 1747, 'Glimepiride'), ('CHEBI_3764', 'clotrimazole', 1776, 'Clonidine'), ('CHEBI_9649', 'trandolapril', 1787, 'Tramadol'), ('CHEBI_28864', 'tobramycin', 1797, 'Tobramycin'), ('CHEBI_5784', 'hydroflumethiazide', 1822, 'Hydrochlorothiazide'), ('CHEBI_6721', 'Megastachine', 1843, 'Medroxyprogesterone'), ('CHEBI_6801', 'metformin', 1864, 'Metformin'), ('CHEBI_48548', 'triflyl group', 1875, 'RisperidoneLack'), ('CHEBI_28384', 'vitamin K', 1959, 'Vitamin E'), ('CHEBI_82427', 'orange G', 1970, 'CoQ10'), ('CHEBI_60211', 'compound Z', 2307, 'medication')]
PMC4896250	4/2016	S1579-PMC4896250	['a111 comparison of different medical treatment options for crswnp: Doxycycline, Methylprednisolone, Mepolizumab, omalizumab\n\nels de schryver, lien calus, philippe gevaert, thibaut van zele, claus bachert\n\nghent university, belgium\n\ncorrespondence: els de schryver â€“ university hospital ghent, belgium\nbackground : chronic rhinosinusitis with Nasal polyps is hard to treat.']	N/A	N/A	[('CHEBI_50845', 'doxycycline', 67, 'Doxycycline'), ('CHEBI_52498', 'zineb', 80, 'methylprednisolone'), ('CHEBI_66701', '(+)-N-(methoxycarbonyl)-N-norboldine', 100, 'mepolizumab'), ('UBERON_0000004', 'nose', 342, 'nasal')]
PMC4896250	4/2016	S1582-PMC4896250	['methods : in total, 100 patients were randomly assigned to receive Doxycycline for 20 days (n=14), Methylprednisolone in decreasing doses for 20 days (n=14), mepolizumab 2 single intravenous injections (n=20), omalizumab 2 to 4 subcutaneous doses (n=15) or placebo (n=37) in three separate clinical double-blind, Placebo-controlled trials.']	N/A	N/A	[('CHEBI_50845', 'doxycycline', 67, 'doxycycline'), ('CHEBI_52498', 'zineb', 99, 'methylprednisolone'), ('CHEBI_26130', 'biological pigment', 313, 'placebo')]
